UK AZN Overview Stock Screener Earnings Calendar Sectors Search Ticker | AZNU.K.: London Watchlist You must be logged in to create alerts Closed Last Updated:Jan 7, 2025 4:39 p.m.GMTDelayed quote p10,668 -44-0.41% Previous Close
Data as of Jan 10 2025. Currency figures normalised to AstraZeneca PLC's reporting currency: UK Pound GBX 21.62%Per cent of shares held by top holders HolderShares% Held BlackRock Investment Management (UK) Ltd.as of 31 Dec 202368.51m4.42% ...
Hardman & Co Insight: Survival of the UK life sciences sector For two years running, the Hardman & Co Healthcare index has declined, underperforming both the FTSE... View report 9 November 2023 In-line Q3; strong operational performance prompts outlook upgrade The Q3 results were in line with...
ASTRAZENECA, the UK's number two drug company, has one of the richest share price valuations in the pharmaceuticals industry - and its results this week will go some way to showing whether this is justified.Foley, Stephen
AstraZeneca PLC price|AstraZeneca PLC Quote Zacks Rank & Key Picks AstraZeneca carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the overall healthcare sector includeArcturus TherapeuticsARCT,BioventusBVSandFulcrum TherapeuticsFULC, each sporting a Zacks Rank #1 (Strong Buy) at presen...
Following the vaccine’s UK approval, AlphaValue analyst Amandeep Goyal upgraded the stock to Buy from Sell as he argues that “sentiment around Astra’s share price should improve finally.” Goyal also raised AZN’s premium on peer-based multiples to 40% from 35% to account f...
AstraZeneca warns of shifting UK vaccine production to US Deadlock with the new Labour government over plans to cut state aid, the Financial Times reported on Thursday Fri Aug 23 2024 - 07:21 Ryanair dominates Irish market with share buyback announcement ...
Yet that is what AstraZeneca did this week. Although David Brennan’s bonus was trimmed by the UK’s second-biggest pharmaceuticals group by sales, his overall pay still rose by 11 per cent last year, even excluding the more than half that came from a long-term incentive scheme. * ...
AstraZeneca AstraZeneca PLC Public LSE, NYSE and OMX: AZNFounded6 April 1999 by mergerHeadquartersLondon, England, UKKey peopleDavid Brennan CEOTony Zook
AstraZeneca has five strategic research and development hubs located in Cambridge, UK; Gothenburg, Sweden; Shanghai, China; Gaithersburg, Maryland (USA); and Boston, Massachusetts (USA). To effectively manage communication with existing investors and build relationships with new ones, the IR team pr...